Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura

References

• Moschcowitz, E. (1924). Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease, Proc. NY. Pathol. Soc., 24, 21–24.
   Google Scholar
• Petitt, R. M. (1980). TTP: A thirty year review, Semin. Thromb. Hemost., 6, 350–355.
   PubMed Web of Science ®Google Scholar
• Amorosi, E. L. and Ultmann, J. E. (1966). Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature, Medicine, 45, 139–159.
   Web of Science ®Google Scholar
• Kennedy, S. S., Zacharski, L. R. and Beck, J. R. (1980). Thrombotic thrombocytopenic purpura: Analysis of 48 unselected cases, Semin. Thromb. Hemost., 6, 341–349.
   PubMed Web of Science ®Google Scholar
• Ridolfi, R. L. and Bell, W. R. (1981). Thrombotic thrombocytopenic purpura: Report of 25 cases and a review of the literature, Medicine, 60, 413–428.
   PubMed Web of Science ®Google Scholar
• Symmers, W. St. C. (1952). Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy), Br. Med. J., 2, 897–903.
   PubMed Web of Science ®Google Scholar
• Baehr, G., Klemperer, P. and Schifrin, A. (1936). An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles, Trans. Assoc. Am. Physicians, 51, 43–58.
   Google Scholar
• Koenig, D. W., Barley-Maloney, L. and Daniel, T. O. (1993). A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies, J. Clin. Immun., 13, 204–211.
   PubMed Web of Science ®Google Scholar
• Umibe, T., Nawata, Y., Mori, N., et al. (1994). Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome, Ryumachi, 34, 981–987.
   PubMedGoogle Scholar
• Tandon, N. N., Rock, G. and Jamieson, G. A. (1994). Anti-CD36 antibodies in thrombotic thrombocytopenic purpura, Br. J. Haematol., 88, 816–825.
   PubMed Web of Science ®Google Scholar
• Wada, H., Minami, N. and Shirakawa, S. (1993). Cytokine levels in patients with thrombotic thrombocytopenic purpura, Np. R. Jpn. J. Clin. Med., 51, 151–154.
   PubMedGoogle Scholar
• Laurence, J. and Mitra, D. (1997). Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome, Sem. Hematol, 34, 98–105.
   PubMed Web of Science ®Google Scholar
• Chen, S. and Lian, E. C.-Y. (1988). Purification and some properties of a 59 kDa platelet-aggregating protein from the plasma of a patient with thrombotic thrombocytopenic purpura (abstr), Blood, 72, 318a.
   Google Scholar
• Siddiqui, F. A. and Lian, E. C.-Y. (1985). Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma, J. Clin. Invest., 76, 1330–1337.
   PubMed Web of Science ®Google Scholar
• Siddiqui, F. A. and Lian, E. C.-Y. (1992). Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36), Biochem. Intern., 27, 485–496.
   PubMedGoogle Scholar
• Asada, Y., Sumiyoshi, A., Hayashi, T., et al. (1985). Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen, Thromb. Res., 38, 469–479.
   PubMed Web of Science ®Google Scholar
• Asada, Y. and Sumiyoshi, A. (1993). Histopathology of thrombotic thrombocytopenic purpura, Np. R. Jpn. J. Clin. Med., 51, 159–162.
   PubMedGoogle Scholar
• Moake, J. L., Turner, N. A., Stathopoulos, N. A., et al. (1986). Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation, J. Clin. Invest., 78, 1456–1461.
   PubMed Web of Science ®Google Scholar
• Moake, J. L. and McPherson, P. D. (1989). Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, Am. J. Med., 87, 3–9N.
   PubMed Web of Science ®Google Scholar
• Moake, J. L., Rudy, C. K., Troll, J. H., et al. (1982). Unusually large plasma factor VIII: von Willebrand factor multimeters in chronic relapsing thrombotic thrombocytopenic purpura, N. Engl. J. Med., 307, 1432–1435.
   PubMed Web of Science ®Google Scholar
• Chintagumpala, M., Hurwitz, R., Moake, J., et al. (1992). Chronic relapsing thrombotic thrombocytopenic purpura in infacts with large von Willebrand factor multimers during remission, J. Pediatr., 120, 49–53.
   PubMed Web of Science ®Google Scholar
• Furlan, M., Robles, R., Solenthaler, M. and Lammle, B. (1998). Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839–2846.
   PubMed Web of Science ®Google Scholar
• Furlan, M., Robles, R., Galbusera, M., et al. (1998). Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N. Engl. J. Med., 339, 1578–1584.
   PubMed Web of Science ®Google Scholar
• Rubenstein, M. A., Kagan, B. M., MacGillviray, M. H., et al. (1959). Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions, Ann. Intern. Med., 51, 1409–1419.
   PubMed Web of Science ®Google Scholar
• Bukowski, R. M., Hewlett, J. S. and Reimer, R. R. (1981). Therapy of thrombotic thrombocytopenic purpura: an overview, Semin. Thromb. Hemost, 7, 1–8.
   PubMed Web of Science ®Google Scholar
• Pisciotto, P., Rosen, D., Silver, H., et al. (1983). Treatment of thrombotic thrombocytopenic purpura. Evaluation of plasma exchange and review of the literature, Vox Sang, 45, 185–196.
   PubMed Web of Science ®Google Scholar
• Blitzer, J. B., Granfortuna, J. M., Gottlieb, A. J., et al. (1987). Thrombotic thrombocytopenic purpura: Treatment with plasma exchange, Am. J. Hematol., 24, 329–339.
   PubMed Web of Science ®Google Scholar
• Pereira, A., Mazzara, R., Monteagudo, J., et al. (1995). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: A multivariate analysis of factors predicting the response to plasma exchange, Ann. Hematol., 70, 319–323.
   PubMed Web of Science ®Google Scholar
• Byrnes, J. J. and Khurana, M. (1977). Treatment of thrombotic thrombocytopenic purpura with plasma, N. Engl. J. Med., 297, 1386–1389.
   PubMed Web of Science ®Google Scholar
• Moake, J. L., Byrnes, J. J., Troll, J. H., et al. (1985). Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic thrombotic thrombocytopenic purpura, Blood, 65, 1232–1236.
   PubMed Web of Science ®Google Scholar
• Naumovski, L. and Pillsbury, H. E. (1991). Treatment of thrombotic thrombocytopenic purpura with cryosupernatant (letter), Am. J. Hematol., 38, 250–251.
   PubMed Web of Science ®Google Scholar
• Obrador, G. T., Zeigler, Z. R., Shadduck, R. K., et al. (1993). Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura, Am. J. Hematol., 42, 217–220.
   PubMed Web of Science ®Google Scholar
• Taft, E. G. (1990). Advances in the treatment of thrombotic thrombocytopenic purpura, Prog. Clin. Biol. Res., 337, 151–155.
   PubMedGoogle Scholar
• Bell, W. R., Braine, H. G., Ness, P. M., et al. (1991). Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients, N. Engl. J. Med., 325, 398–403.
   PubMed Web of Science ®Google Scholar
• Onundarson, P. T., Rowe, L. M., Heal, J. M., et al. (1992). Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution, Arch. Int. Med., 152, 791–796.
   PubMedGoogle Scholar
• Sutton, D. M., Nair, R. C., Rock, G., et al. (1989). Complications of plasma exchange. Canadian Apheresis Study Group, Transfusion, 29, 124–127.
   PubMed Web of Science ®Google Scholar
• Novitzky, N., Jacobs, P. and Rosenstrauch, W. (1994). The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange? Brit. J. Haematol., 87, 317–320.
   PubMed Web of Science ®Google Scholar
• Rock, G. A., Shumak, K. H., Buskard, N. A., et al. (1991). Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N. Engl. J. Med., 325, 393–397.
   PubMed Web of Science ®Google Scholar
• Bukowski, R. M., Hewlett, J. S. and Reimer, R. R. (1981). Therapy of thrombotic thrombocytopenic purpura: an overview, Semin. Thromb. Hemost., 7, 1–8.
   PubMed Web of Science ®Google Scholar
• George, J. N. and El-Harake, M. (1995). Thrombocytopenia due to enhanced platelet destruction by nonimmunological mechanisms. In Williams Hematology (ed 5), edited by E. Beutler, M. A. Lichtman, B. S. Coller, et al., pp. 290–1315, New York. McGraw-Hill.
   Google Scholar
• Myers, T. J., Wakem, C. J., Ball, E. D., et al. (1980). Thrombotic thrombocytopenic purpura: Combined treatment with plasma exchange and antiplatelet agents, Ann. Intern. Med., 92, 149–155.
   PubMed Web of Science ®Google Scholar
• Del Zoppo, G. L. (1987). Antiplatelet therapy in thrombotic thrombocytopenic purpura, Semin. Hematol., 24, 130–139.
   PubMed Web of Science ®Google Scholar
• Breckenridge, R. L. Jr., Stolberg, L. A., Pineda, A. A., et al. (1982). Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience, J. Clin. Apheresis, 1, 6–13.
   PubMedGoogle Scholar
• Rosove, M. H., Ho, W. G. and Goldfinger, D. (1982). Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura, Ann. Intern. Med., 96, 27–33.
   PubMed Web of Science ®Google Scholar
• Gordon, L. I., Kwaan, H. C. and Rossi, E. C. (1987). Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy, Semin. Hematol., 24, 194–201.
   PubMed Web of Science ®Google Scholar
• Welborn, J. L., Emrick, P. and Acevedo, M. (1990). Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis, Am. J. Hematol., 35, 18–21.
   PubMed Web of Science ®Google Scholar
• Levin, M. and Grunwald, H. W. (1991). Use of vincristine in refractory thrombotic thrombocytopenic purpura, Acta Haematol., 85, 37–40.
   PubMed Web of Science ®Google Scholar
• O'Connor, N. T., Bruce-Jones, P. and Hill, L. F. (1992). Vincristine therapy for thrombotic thrombocytopenic purpura, Am. J. Hematol., 39, 234–236.
   PubMed Web of Science ®Google Scholar
• Bobbio-Pallavicini, E., Porta, C., Centurioni, L., et al. (1994). Vincristine sulfate for the treatment of thrombocytopenic purpura refractory to plasmaexchange. The Italian Cooperative Group for TTP, Eur. J. Haematol., 52, 222–226.
   PubMedGoogle Scholar
• Cuttner, J. (1980). Thrombotic thrombocytopenic purpura: A 10-year experience, Blood, 56, 302–306.
   PubMed Web of Science ®Google Scholar
• Bukowski, R. M. (1982). Thrombotic thrombocytopenic purpura: A review, Prog. Hemostasis Thromb., 6, 287–337.
   PubMedGoogle Scholar
• Schneider, P. A., Rayner, A. A., Linker, C. A., et al. (1985). The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura, Ann. Surg., 202, 318–321.
   PubMed Web of Science ®Google Scholar
• Thompson, C. E., Damon, L. E., Reis, C. A., et al. (1992). Thrombotic microangiopathies in the 1980's: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic, Blood, 80, 1890–1895.
   PubMed Web of Science ®Google Scholar
• Winslow, G. A. and Nelson, E. W. (1995). Thrombotic thrombocytopenic purpura: Indications for and results of splenectomy, Am. J. Surg., 170, 558–561.
   PubMed Web of Science ®Google Scholar
• Liu, E. T., Linker, C. A. and Shuman, M. A. (1986). Management of treatment failures in thrombotic thrombocytopenic purpura, Am. J. Hematol., 23, 347–361.
   PubMed Web of Science ®Google Scholar
• Veltman, G. A., Brand, A., Leeksma, O. C., et al. (1995). The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura, Ann. Hematol., 70, 231–236.
   PubMed Web of Science ®Google Scholar
• Lian, E. C.-Y., Mui, P. T. K., Siddiqui, F. A., et al. (1984). Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G, J. Clin. Invest., 73, 548–555.
   PubMed Web of Science ®Google Scholar
• Viero, P., Cortellazzo, S., Buelli, M., et al. (1986). Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment (letter), Ann. Intern. Med., 104, 282.
   PubMed Web of Science ®Google Scholar
• Finn, N. G., Wang, J. C. and Hong, K. J. (1987). High dose intravenous immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura, Arch. Intern. Med., 147, 2165–2167.
   PubMedGoogle Scholar
• Kolodziej, M. (1993). Case report: High-dose intravenous immunoglobulin as therapy for thrombotic thrombocytopenic purpura, Am. J. Med. Sci., 305, 101–102.
   PubMed Web of Science ®Google Scholar
• Finazzi, G., Bellavita, P., Falanga, A., et al. (1992). Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome, Am. J. Hematol., 41, 165–169.
   PubMed Web of Science ®Google Scholar
• Durand, J. M., Lefevre, P., Kaplanski, G., et al. (1993). Ineffectiveness of high-dose intravenous gammaglobulin infusion in thrombotic thrombocytopenic purpura (letter), Am. J. Hematol., 42, 234.
   PubMed Web of Science ®Google Scholar
• Drew, M.J. (1994). Resolution of refractory, classic thrombotic thrombocytopenic purpura after a staphylococcal protein A immunoadsorption, Transfusion, 34, 536–538.
   PubMed Web of Science ®Google Scholar
• Harkness, D. R., Byrnes, J.J., Lian, E. C.-Y., et al. (1981). Hazard of platelet transfusion in thrombotic thrombocytopenic purpura, J.A.M.A., 246, 1931–1933.
   PubMed Web of Science ®Google Scholar
• Byrnes, J. J. (1981). Plasma infusion in the treatment of thrombotic thrombocytopenic purpura, Semin. Thromb. Hemost., 7, 9–14.
   PubMed Web of Science ®Google Scholar
• Habib, R., Gagnadoux, M. F. and Broyer, M. (1981). Hemolytic uremic syndrome in children and arterial hypertension, Arch. Mal Coeur Vaiss, 74, 37–45.
   PubMedGoogle Scholar
• Siegler, R. L. (1988). Management of hemolytic uremic syndrome, J. Pediatr., 112, 1014–1020.
   PubMed Web of Science ®Google Scholar